Does heterogeneity matter in the estimation of tumour budding and tumour stroma ratio in colon cancer?

BACKGROUND: Tumour budding (TB) and Tumour Stroma Ratio (TSR) may be rewarding in the treatment stratification of patients with stage II colon cancer. However, lack of standardization may exclude these parameters from being used in a clinical setting. The purpose of this methodologic study was to co...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Diagn Pathol
Asıl Yazarlar: Eriksen, Ann C., Andersen, Johnnie B., Lindebjerg, Jan, dePont Christensen, René, Hansen, Torben F., Kjær-Frifeldt, Sanne, Sørensen, Flemming B.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2018
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5859415/
https://ncbi.nlm.nih.gov/pubmed/29558947
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13000-018-0697-9
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller